CJC-1295 + Ipamorelin Research Guide

Omega Research Guide

CJC-1295 + Ipamorelin Research Guide

The CJC-1295 (No DAC) and Ipamorelin blend pairs two growth hormone secretagogues that act on complementary pathways. This guide explains what each peptide is, how the blend is studied, the difference between the No DAC and DAC versions, and what Australian researchers should look for when sourcing research-grade material.

View CJC-1295 + Ipamorelin Buy Peptides Australia View BAC Water

What is the CJC-1295 + Ipamorelin blend?

This is a dual peptide research blend that combines CJC-1295 (No DAC), also known as Modified GRF (1-29), with Ipamorelin in a single lyophilised vial containing 5mg of each. Both are growth hormone secretagogues, meaning they are studied for their ability to stimulate the release of growth hormone, but they do so through two different mechanisms, which is why they are frequently studied together. It is supplied strictly for laboratory research use only.

Research-use note: This blend is not approved for human or veterinary use in Australia. It is supplied strictly for laboratory research purposes only.

The two peptides

Peptide Class Research role
CJC-1295 (No DAC) GHRH analog (Modified GRF 1-29) Studied as a short-acting growth-hormone-releasing hormone analog that stimulates the GH pathway.
Ipamorelin Selective GH secretagogue (GHRP) Studied as a selective secretagogue reported to have minimal effect on cortisol and prolactin.

How the blend is studied

The rationale for combining the two peptides is that they act on complementary pathways. CJC-1295 (No DAC) is studied as a GHRH analog, while Ipamorelin is studied as a growth hormone releasing peptide (GHRP). In research models the two are examined together for their combined effect on pulsatile growth hormone release and downstream IGF-1 signalling. Common research areas include GH secretion, recovery and body-composition research models, and metabolic signalling.

No DAC vs DAC: what is the difference?

CJC-1295 is studied in two forms. The No DAC version, Modified GRF (1-29), has a shorter activity profile. The DAC version carries a Drug Affinity Complex that extends its half-life considerably in research settings. The No DAC form is often paired with Ipamorelin because its shorter, more pulse-like profile is studied alongside the secretagogue action of Ipamorelin. For the long-acting form, see CJC-1295 (DAC).

Reconstitution and handling

The blend is supplied lyophilised. For laboratory preparation, researchers typically reconstitute with bacteriostatic water, added slowly down the inside wall of the vial and swirled gently rather than shaken. Store the reconstituted solution at 2 to 8°C and use within 28 days, following the relevant research protocol.

Storage considerations

  • Store the lyophilised vial at 2 to 8°C, away from light and moisture
  • Avoid repeated freeze-thaw cycles
  • After reconstitution, keep refrigerated at 2 to 8°C and use within 28 days
  • Record preparation dates and handling details

Research-grade material: what to look for

Because this is a blend of two peptides, verifying both purity and the ratio between compounds matters. A reliable supplier should provide a third-party Certificate of Analysis, verified purity, clear composition labelling and research-use-only disclaimers. Omega Peptides Australia supplies the CJC-1295 + Ipamorelin blend as a COA-verified lyophilised powder tested to above 99% purity.

CJC-1295 and Ipamorelin in Australia

This blend is not available through pharmacies or standard therapeutic channels in Australia and may only be supplied by specialist research compound suppliers for laboratory research use. You can buy CJC-1295 and Ipamorelin in Australia from Omega Peptides Australia with COA verification and fast domestic dispatch.

You can also browse the full range of research peptides for sale in Australia from Omega Peptides Australia.

Frequently Asked Questions

What is the CJC-1295 (No DAC) + Ipamorelin blend?

A dual growth hormone secretagogue research blend pairing CJC-1295 (No DAC), or Modified GRF (1-29), with Ipamorelin, supplied as a high-purity COA-verified lyophilised powder for laboratory research.

What is in each vial?

A total of 10mg: 5mg CJC-1295 (No DAC) and 5mg Ipamorelin.

What is the difference between No DAC and DAC?

CJC-1295 (No DAC), or Modified GRF (1-29), has a shorter activity profile, while the DAC version carries a Drug Affinity Complex that extends its half-life in research settings.

How does the blend work?

The two peptides act on complementary pathways, CJC-1295 (No DAC) as a GHRH analog and Ipamorelin as a selective GH secretagogue, studied together for their combined effect on growth hormone release.

Where can I buy CJC-1295 and Ipamorelin in Australia?

Directly from Omega Peptides Australia, dispatched domestically with COA verification and fast local delivery.

References

  • Teichman SL, et al. Prolonged stimulation of growth hormone and IGF-1 secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism, 2006.
  • Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 1998.

Research-Grade CJC-1295 + Ipamorelin from Omega Peptides Australia

Supplied as a COA-verified lyophilised blend for laboratory research use only, with domestic Australian dispatch.

View the blend Buy Peptides Australia
This article is for research and educational purposes only. The CJC-1295 + Ipamorelin blend is not approved for human or veterinary use in Australia. All products supplied by Omega Peptides Australia are intended strictly for laboratory research use only.